SEC Form 4 · Insider disclosures

Recent Insider Buying

Recent purchases grouped by company. A P-code purchase may be open-market or private; check the filing for context.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

118 companies · 312 rows
UXIN

Uxin Ltd

Purchase total ≈ US$27.9K

6 transaction rows · 6 filings

Dai Kun

Purchase
CEO / Director disclosed purchase of 4,002 shares

Disclosed 10b5-1 trading plan

Purchase increased prior indirect holdings by approximately 3.76%; approximately 110K shares afterward

Calculated transaction value approximately US$3.76K

Dai Kun

Purchase
CEO / Director disclosed purchase of 5,541 shares

Disclosed 10b5-1 trading plan

Purchase increased prior indirect holdings by approximately 5.50%; approximately 106K shares afterward

Calculated transaction value approximately US$5.26K
Show 4 more transaction rows

Dai Kun

Purchase
CEO / Director disclosed purchase of 6,211 shares

Disclosed 10b5-1 trading plan

Purchase increased prior indirect holdings by approximately 6.57%; approximately 101K shares afterward

Calculated transaction value approximately US$6.09K

Dai Kun

Purchase
CEO / Director disclosed purchase of 2,548 shares

Disclosed 10b5-1 trading plan

Purchase increased prior indirect holdings by approximately 2.77%; approximately 94.5K shares afterward

Calculated transaction value approximately US$2.62K

Dai Kun

Purchase
CEO / Director disclosed purchase of 4,100 shares

Disclosed 10b5-1 trading plan

Purchase increased prior indirect holdings by approximately 4.66%; approximately 91.9K shares afterward

Calculated transaction value approximately US$4.27K

Dai Kun

Purchase
CEO / Director disclosed purchase of 5,400 shares

Disclosed 10b5-1 trading plan

Purchase increased prior indirect holdings by approximately 6.55%; approximately 87.8K shares afterward

Calculated transaction value approximately US$5.91K
FBK

FB Financial Corp

Purchase total ≈ US$1.54M

2 transaction rows · 1 filings

INGRAM ORRIN H II

Purchase
Director disclosed purchase of 15,591 shares

Filing did not check the 10b5-1 plan indicator

Approximately 111K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$821.33K

INGRAM ORRIN H II

Purchase
Director disclosed purchase of 13,490 shares

Filing did not check the 10b5-1 plan indicator

Approximately 124K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$716.45K
BPRE

Bluerock Private Real Estate Fund

Purchase total ≈ US$11.29M

10 transaction rows · 5 filings

KAMFAR RAMIN

Purchase
Director disclosed purchase of 64,662 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.51M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$793.45K

KAMFAR RAMIN

Purchase
Director disclosed purchase of 92,029 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.61M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.14M
Show 8 more transaction rows

KAMFAR RAMIN

Purchase
Director disclosed purchase of 114,864 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.72M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.41M

KAMFAR RAMIN

Purchase
Director disclosed purchase of 92,475 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.35M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.16M

KAMFAR RAMIN

Purchase
Director disclosed purchase of 101,753 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.45M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.26M

MacDonald Ryan S

Purchase
Director disclosed purchase of 120 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.28%; approximately 42.4K shares afterward

Calculated transaction value approximately US$1.54K

Ruddy Jordan B.

Purchase
Officer disclosed purchase of 3,520 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 25.74%; approximately 17.2K shares afterward

Calculated transaction value approximately US$44.32K

KAMFAR RAMIN

Purchase
Director disclosed purchase of 158,984 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.99M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.06M

KAMFAR RAMIN

Purchase
Director disclosed purchase of 110,964 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.1M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.43M

KAMFAR RAMIN

Purchase
Director disclosed purchase of 157,661 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.25M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.99M
GRCE

Grace Therapeutics, Inc.

Purchase total ≈ US$144.18K

4 transaction rows · 2 filings

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 4,256 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior indirect holdings by approximately 0.14%; approximately 2.95M shares afterward

Calculated transaction value approximately US$8K

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 11,233 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.88M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$21.73K
Show 2 more transaction rows

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 23,485 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.91M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$45.69K

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 36,347 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.94M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$68.76K
none

WILSON BANK HOLDING CO

Purchase total ≈ US$1.7K

1 transaction rows · 1 filings

MCDEARMAN JOHN

Purchase
CEO / Director disclosed purchase of 20 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.08%; approximately 22.4K shares afterward

Calculated transaction value approximately US$1.7K
NONE

MSD Investment Corp.

Purchase total ≈ US$310.91K

1 transaction rows · 1 filings

Williams Brian S

Purchase
Officer disclosed purchase of 13,129.501 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 36.12%; approximately 49.5K shares afterward

Calculated transaction value approximately US$310.91K
CRF

CORNERSTONE TOTAL RETURN FUND INC

Purchase total ≈ US$117.6K

1 transaction rows · 1 filings

Bradshaw Joshua

Purchase
Officer / Director disclosed purchase of 20,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 4132.23%; approximately 20.5K shares afterward

Calculated transaction value approximately US$117.6K
CLM

Cornerstone Strategic Investment Fund, Inc.

Purchase total ≈ US$97.28K

1 transaction rows · 1 filings

Bradshaw Joshua

Purchase
Officer / Director disclosed purchase of 16,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 367.30%; approximately 20.4K shares afterward

Calculated transaction value approximately US$97.28K
TENX

TENAX THERAPEUTICS, INC.

Purchase total ≈ US$1.46M

3 transaction rows · 1 filings

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 336,528 shares

Filing did not check the 10b5-1 plan indicator

Approximately 6.86M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$507.01K

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 254,342 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.12M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$405.73K
Show 1 more transaction rows

ADAR1 Capital Management, LLC / Schneeberger Daniel

Purchase
10% owner disclosed purchase of 331,979 shares

Filing did not check the 10b5-1 plan indicator

Approximately 7.45M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$550.69K
PETV

PetVivo Holdings, Inc.

Purchase total ≈ US$56.13K

14 transaction rows · 1 filings

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 9,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$6.12K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 4,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.8K
Show 12 more transaction rows

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 4,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.8K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 4,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.8K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 4,286 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$3.09K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$7.4K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$7.4K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 3,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.1K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 2,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.5M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$1.4K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 6,969 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.6M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$4.81K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 6,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.6M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$4.2K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 3,600 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.6M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2.52K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 6,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.6M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$4.2K

A.L. Sarroff Fund, LLC

Purchase
10% owner disclosed purchase of 6,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 10.6M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$4.49K
NBIS

Nebius Group N.V.

Purchase total ≈ US$125.19K

5 transaction rows · 3 filings

Grimme Arne

Purchase
Director disclosed purchase of 151 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 6.48K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$24.86K

Grimme Arne

Purchase
Director disclosed purchase of 148 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 6.63K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$24.86K
Show 3 more transaction rows

Grimme Arne

Purchase
Director disclosed purchase of 148 shares

Disclosed 10b5-1 trading plan

Purchase increased prior direct holdings by approximately 2.39%; approximately 6.33K shares afterward

Calculated transaction value approximately US$25.16K

Grimme Arne

Purchase
Director disclosed purchase of 148 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 6.03K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$25.16K

Grimme Arne

Purchase
Director disclosed purchase of 148 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 6.18K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$25.16K
VRXA

Veraxa Biotech AG - Post de-SPAC

Purchase total ≈ US$32.7K

1 transaction rows · 1 filings

Ziegler Christoph Samuel

Purchase
Director disclosed purchase of 30,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 378.21%; approximately 37.9K shares afterward

Calculated transaction value approximately US$32.7K
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗